-
公开(公告)号:US11331105B2
公开(公告)日:2022-05-17
申请号:US16342968
申请日:2017-10-17
申请人: Aria CV, Inc.
摘要: A device for reducing pulsatile pressure within a vessel to treat heart disease, such as pulmonary hypertension, includes a compliant body structured to expand and contract upon changes in pressure within the vessel, a reservoir structured for holding a fluid therein, and a conduit extending between and fluidly coupling the reservoir and the compliant body, wherein the device includes a graphene-polymer composite designed to resist diffusion of the fluid through the device.
-
公开(公告)号:US09333328B2
公开(公告)日:2016-05-10
申请号:US14253127
申请日:2014-04-15
申请人: ARIA CV, INC.
发明人: John Scandurra , Karl Vollmers
CPC分类号: A61M29/02 , A61M1/1005 , A61M1/1008 , A61M1/1032 , A61M1/1044 , A61M1/106 , A61M1/107 , A61M1/1072 , A61M1/1074 , A61M1/1086 , A61M1/12 , A61M1/125 , A61M25/04 , A61M25/1018 , A61M25/10184 , A61M2205/33 , A61M2205/3303
摘要: A device for reducing pressure within a lumen includes a reservoir structured for holding a fluid therein, an injection port in fluid communication with the reservoir, a compliant body structured to expand and contract upon changes in pressure, and a conduit extending between and fluidly coupling the reservoir and the compliant body. The fluid may be a compressible or a noncompressible fluid.
-
公开(公告)号:US11511089B2
公开(公告)日:2022-11-29
申请号:US16900794
申请日:2020-06-12
申请人: Aria CV, Inc.
发明人: Karl Vollmers , John Scandurra
IPC分类号: A61M25/10 , A61M39/02 , A61M5/172 , A61B17/12 , A61M60/135 , A61M60/869 , A61M60/585 , A61M60/523 , A61M60/295 , A61M60/538 , A61M60/515 , A61M5/50 , A61M25/04 , A61M25/06 , A61M29/02 , A61B17/00 , A61B90/00
摘要: A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e.g., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and the reservoir is adapted to be implanted subcutaneously. The external components may include a clinical controller component, monitoring software configured to run a clinician's computer, a patient monitoring device, and a mobile application configured to run on a patient's mobile device.
-
公开(公告)号:US11406803B2
公开(公告)日:2022-08-09
申请号:US16989830
申请日:2020-08-10
申请人: Aria CV, Inc.
发明人: John Scandurra , Karl Vollmers
IPC分类号: A61M25/10 , A61M29/02 , A61M25/04 , A61M60/135 , A61M60/405 , A61M60/869 , A61M60/17 , A61M60/40 , A61M60/50 , A61M60/122 , A61M60/274 , A61M60/562 , A61M60/857
摘要: A device for reducing pressure within a lumen includes a reservoir structured for holding a fluid therein, an injection port in fluid communication with the reservoir, a compliant body structured to expand and contract upon changes in pressure, and a conduit extending between and fluidly coupling the reservoir and the compliant body. The fluid may be a compressible or a noncompressible fluid.
-
公开(公告)号:US10751519B2
公开(公告)日:2020-08-25
申请号:US14955109
申请日:2015-12-01
申请人: Aria CV, Inc
发明人: John Scandurra , Karl Vollmers
摘要: A device for reducing pressure within a lumen includes a reservoir structured for holding a fluid therein, an injection port in fluid communication with the reservoir, a compliant body structured to expand and contract upon changes in pressure, and a conduit extending between and fluidly coupling the reservoir and the compliant body. The fluid may be a compressible or a noncompressible fluid.
-
公开(公告)号:US11938291B2
公开(公告)日:2024-03-26
申请号:US17816534
申请日:2022-08-01
申请人: Aria CV, Inc.
发明人: John Scandurra , Karl Vollmers
IPC分类号: A61M25/10 , A61M25/04 , A61M29/02 , A61M60/135 , A61M60/295 , A61M60/405 , A61M60/497 , A61M60/531 , A61M60/869 , A61M60/122 , A61M60/17 , A61M60/274 , A61M60/40 , A61M60/50 , A61M60/562 , A61M60/857
CPC分类号: A61M29/02 , A61M25/04 , A61M60/135 , A61M60/295 , A61M60/405 , A61M60/497 , A61M60/531 , A61M60/869 , A61M25/1018 , A61M25/10184 , A61M60/122 , A61M60/17 , A61M60/274 , A61M60/40 , A61M60/50 , A61M60/562 , A61M60/857 , A61M2205/33 , A61M2205/3303
摘要: A device for reducing pressure within a lumen includes a reservoir structured for holding a fluid therein, an injection port in fluid communication with the reservoir, a compliant body structured to expand and contract upon changes in pressure, and a conduit extending between and fluidly coupling the reservoir and the compliant body. The fluid may be a compressible or a noncompressible fluid.
-
公开(公告)号:US09801989B2
公开(公告)日:2017-10-31
申请号:US15474902
申请日:2017-03-30
申请人: Aria CV, Inc.
发明人: Karl Vollmers , John Scandurra
CPC分类号: A61M1/1086 , A61B17/12036 , A61B17/1204 , A61B17/12136 , A61B2017/00022 , A61B2017/00212 , A61B2017/00221 , A61B2090/064 , A61M1/1044 , A61M1/1072 , A61M1/125 , A61M5/1723 , A61M5/5086 , A61M25/04 , A61M25/0662 , A61M25/104 , A61M29/02 , A61M39/0208 , A61M2025/0681 , A61M2205/04 , A61M2205/18 , A61M2205/3324 , A61M2205/3327 , A61M2205/3334 , A61M2205/3368 , A61M2205/3389 , A61M2205/3515 , A61M2205/3523 , A61M2205/505 , A61M2210/12 , A61M2230/04
摘要: A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e.g., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and the reservoir is adapted to be implanted subcutaneously. The external components may include a clinical controller component, monitoring software configured to run a clinician's computer, a patient monitoring device, and a mobile application configured to run on a patient's mobile device.
-
公开(公告)号:US09039725B1
公开(公告)日:2015-05-26
申请号:US14531846
申请日:2014-11-03
申请人: ARIA CV, INC.
发明人: Karl Vollmers , John Scandurra
CPC分类号: A61M1/1086 , A61B17/12036 , A61B17/1204 , A61B17/12136 , A61B2017/00022 , A61B2017/00212 , A61B2017/00221 , A61B2090/064 , A61M1/1044 , A61M1/1072 , A61M1/125 , A61M5/1723 , A61M5/5086 , A61M25/04 , A61M25/0662 , A61M25/104 , A61M29/02 , A61M39/0208 , A61M2025/0681 , A61M2205/04 , A61M2205/18 , A61M2205/3324 , A61M2205/3327 , A61M2205/3334 , A61M2205/3368 , A61M2205/3389 , A61M2205/3515 , A61M2205/3523 , A61M2205/505 , A61M2210/12 , A61M2230/04
摘要: A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e.g., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and the reservoir is adapted to be implanted subcutaneously. The external components may include a clinical controller component, monitoring software configured to run a clinician's computer, a patient monitoring device, and a mobile application configured to run on a patient's mobile device.
摘要翻译: 提供了一种用于治疗心脏病的系统,例如肺动脉高压或右心衰竭,包括可植入组件和用于监测可植入组件的外部组件。 可植入部件可以包括通过导管联接到储存器的柔顺构件,例如球囊。 优选地,顺应性构件适于植入肺动脉中,并且储库适于被皮下植入。 外部组件可以包括临床控制器组件,被配置为运行临床医生的计算机的监视软件,患者监视设备和被配置为在患者的移动设备上运行的移动应用。
-
公开(公告)号:US08876850B1
公开(公告)日:2014-11-04
申请号:US14309758
申请日:2014-06-19
申请人: Aria CV, Inc.
发明人: Karl Vollmers , John Scandurra
CPC分类号: A61M1/1086 , A61B17/12036 , A61B17/1204 , A61B17/12136 , A61B2017/00022 , A61B2017/00212 , A61B2017/00221 , A61B2090/064 , A61M1/1044 , A61M1/1072 , A61M1/125 , A61M5/1723 , A61M5/5086 , A61M25/04 , A61M25/0662 , A61M25/104 , A61M29/02 , A61M39/0208 , A61M2025/0681 , A61M2205/04 , A61M2205/18 , A61M2205/3324 , A61M2205/3327 , A61M2205/3334 , A61M2205/3368 , A61M2205/3389 , A61M2205/3515 , A61M2205/3523 , A61M2205/505 , A61M2210/12 , A61M2230/04
摘要: A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e.g., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and the reservoir is adapted to be implanted subcutaneously. The external components may include a clinical controller component, monitoring software configured to run a clinician's computer, a patient monitoring device, and a mobile application configured to run on a patient's mobile device.
摘要翻译: 提供了一种用于治疗心脏病的系统,例如肺动脉高压或右心衰竭,包括可植入组件和用于监测可植入组件的外部组件。 可植入部件可以包括通过导管联接到储存器的柔顺构件,例如球囊。 优选地,顺应性构件适于植入肺动脉中,并且储库适于被皮下植入。 外部组件可以包括临床控制器组件,被配置为运行临床医生的计算机的监视软件,患者监视设备和被配置为在患者的移动设备上运行的移动应用。
-
公开(公告)号:US11833343B2
公开(公告)日:2023-12-05
申请号:US17496719
申请日:2021-10-07
申请人: Aria CV, Inc.
发明人: Karl Vollmers , Lynn Zwiers , John Gainor , John Scandurra
IPC分类号: A61M60/869 , A61M60/268 , A61M60/122 , A61M60/135 , A61M60/00 , A61M60/274 , A61B17/12 , A61M1/00 , A61M29/02 , C01B17/00 , C01B17/45 , A61B17/00
CPC分类号: A61M60/869 , A61B17/12022 , A61B17/12027 , A61B17/12036 , A61B17/12109 , A61B17/12131 , A61B17/12136 , A61M1/00 , A61M29/02 , A61M60/00 , A61M60/122 , A61M60/135 , A61M60/268 , A61M60/274 , C01B17/00 , C01B17/45 , C01B17/453 , C01B17/4507 , C01B17/4515 , A61B2017/00535 , A61B2017/00557 , A61M2202/025 , A61M2202/0208 , A61M2202/0225 , A61M2202/04
摘要: Diffusion and infusion resistant implantable devices and methods for reducing pulsatile pressure are provided. The implantable device includes a balloon implantable within a blood vessel of a patient, e.g., the pulmonary artery. The balloon is injected with a fluid mixture comprising a constituent fluid(s) and a diffusion-resistant gas to provide optimal balloon volume and limit fluid diffusion throughout multiple cardiac cycles. The fluid mixture may be pressurized such that the balloon is transitionable between an expanded state and a collapsed state responsive to pressure fluctuations in the blood vessel.
-
-
-
-
-
-
-
-
-